These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

224 related articles for article (PubMed ID: 28166656)

  • 1. Combination of Ceftriaxone and Ampicillin for the Treatment of Enterococcal Endocarditis: A Qualitative Systematic Review.
    Peterson SC; Lau TTY; Ensom MHH
    Ann Pharmacother; 2017 Jun; 51(6):496-503. PubMed ID: 28166656
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Changes in the treatment of Enterococcus faecalis infective endocarditis in Spain in the last 15 years: from ampicillin plus gentamicin to ampicillin plus ceftriaxone.
    Pericas JM; Cervera C; del Rio A; Moreno A; Garcia de la Maria C; Almela M; Falces C; Ninot S; Castañeda X; Armero Y; Soy D; Gatell JM; Marco F; Mestres CA; Miro JM;
    Clin Microbiol Infect; 2014 Dec; 20(12):O1075-83. PubMed ID: 25040215
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Outpatient parenteral antimicrobial therapy in Enterococcus faecalis infective endocarditis.
    Gil-Navarro MV; Lopez-Cortes LE; Luque-Marquez R; Galvez-Acebal J; de Alarcon-Gonzalez A
    J Clin Pharm Ther; 2018 Apr; 43(2):220-223. PubMed ID: 29030859
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Efficacy of ampicillin combined with ceftriaxone and gentamicin in the treatment of experimental endocarditis due to Enterococcus faecalis with no high-level resistance to aminoglycosides.
    Gavaldá J; Onrubia PL; Gómez MT; Gomis X; Ramírez JL; Len O; Rodríguez D; Crespo M; Ruíz I; Pahissa A
    J Antimicrob Chemother; 2003 Sep; 52(3):514-7. PubMed ID: 12917251
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Efficacy of the combination ampicillin plus ceftriaxone in the treatment of a case of enterococcal endocarditis due to Enterococcus faecalis highly resistant to gentamicin: efficacy of the "ex vivo" synergism method.
    Tascini C; Doria R; Leonildi A; Martinelli C; Menichetti F
    J Chemother; 2004 Aug; 16(4):400-3. PubMed ID: 15332717
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Brief communication: treatment of Enterococcus faecalis endocarditis with ampicillin plus ceftriaxone.
    Gavaldà J; Len O; Miró JM; Muñoz P; Montejo M; Alarcón A; de la Torre-Cisneros J; Peña C; Martínez-Lacasa X; Sarria C; Bou G; Aguado JM; Navas E; Romeu J; Marco F; Torres C; Tornos P; Planes A; Falcó V; Almirante B; Pahissa A
    Ann Intern Med; 2007 Apr; 146(8):574-9. PubMed ID: 17438316
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Time to abandon ampicillin plus gentamicin in favour of ampicillin plus ceftriaxone in Enterococcus faecalis infective endocarditis? A meta-analysis of comparative trials.
    Mirna M; Topf A; Schmutzler L; Hoppe UC; Lichtenauer M
    Clin Res Cardiol; 2022 Oct; 111(10):1077-1086. PubMed ID: 34751788
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Ampicillin plus ceftriaxone is as effective as ampicillin plus gentamicin for treating enterococcus faecalis infective endocarditis.
    Fernández-Hidalgo N; Almirante B; Gavaldà J; Gurgui M; Peña C; de Alarcón A; Ruiz J; Vilacosta I; Montejo M; Vallejo N; López-Medrano F; Plata A; López J; Hidalgo-Tenorio C; Gálvez J; Sáez C; Lomas JM; Falcone M; de la Torre J; Martínez-Lacasa X; Pahissa A
    Clin Infect Dis; 2013 May; 56(9):1261-8. PubMed ID: 23392394
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Success of ampicillin plus ceftriaxone rescue therapy for a relapse of Enterococcus faecalis native-valve endocarditis and in vitro data on double beta-lactam activity.
    Miro JM; Cervera C; Garcia-de-la-Maria C; Del Rio A; Armero Y; Mestres CA; Grau JM; Marco F; Moreno A
    Scand J Infect Dis; 2008; 40(11-12):968-72. PubMed ID: 18767002
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Early in vitro development of daptomycin non-susceptibility in high-level aminoglycoside-resistant Enterococcus faecalis predicts the efficacy of the combination of high-dose daptomycin plus ampicillin in an in vivo model of experimental endocarditis.
    Pericàs JM; García-de-la-Mària C; Brunet M; Armero Y; García-González J; Casals G; Almela M; Quintana E; Falces C; Ninot S; Fuster D; Llopis J; Marco F; Moreno A; Miró JM;
    J Antimicrob Chemother; 2017 Jun; 72(6):1714-1722. PubMed ID: 28204495
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Efficacy of ampicillin plus ceftriaxone in treatment of experimental endocarditis due to Enterococcus faecalis strains highly resistant to aminoglycosides.
    Gavaldà J; Torres C; Tenorio C; López P; Zaragoza M; Capdevila JA; Almirante B; Ruiz F; Borrell N; Gomis X; Pigrau C; Baquero F; Pahissa A
    Antimicrob Agents Chemother; 1999 Mar; 43(3):639-46. PubMed ID: 10049280
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effectiveness of ampicillin plus ceftriaxone compared to ampicillin plus gentamicin for treating Enterococcus faecalis infective endocarditis: a noninferiority question not yet properly investigated.
    Solla DJ
    Clin Infect Dis; 2013 Sep; 57(5):768. PubMed ID: 23704125
    [No Abstract]   [Full Text] [Related]  

  • 13. Comparison of Dual β-Lactam therapy to penicillin-aminoglycoside combination in treatment of Enterococcus faecalis infective endocarditis.
    El Rafei A; DeSimone DC; Narichania AD; Sohail MR; Vikram HR; Li Z; Steckelberg JM; Wilson WR; Baddour LM
    J Infect; 2018 Nov; 77(5):398-404. PubMed ID: 29969596
    [TBL] [Abstract][Full Text] [Related]  

  • 14. In vitro synergism and anti-biofilm activity of ampicillin, gentamicin, ceftaroline and ceftriaxone against Enterococcus faecalis.
    Thieme L; Klinger-Strobel M; Hartung A; Stein C; Makarewicz O; Pletz MW
    J Antimicrob Chemother; 2018 Jun; 73(6):1553-1561. PubMed ID: 29506271
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Efficacy of teicoplanin-gentamicin given once a day on the basis of pharmacokinetics in humans for treatment of enterococcal experimental endocarditis.
    López P; Gavaldà J; Martin MT; Almirante B; Gomis X; Azuaje C; Borrell N; Pou L; Falcó V; Pigrau C; Pahissa A
    Antimicrob Agents Chemother; 2001 May; 45(5):1387-93. PubMed ID: 11302800
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Enterococcus faecalis infective endocarditis: focus on clinical aspects.
    Dahl A; Bruun NE
    Expert Rev Cardiovasc Ther; 2013 Sep; 11(9):1247-57. PubMed ID: 24073680
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Infective endocarditis due to high level aminoglycoside resistant Enterococcus faecalis and methicillin resistant coagulase-negative staphylococci presenting with rheumatic manifestations].
    Pişkin N; Akduman D; Aydemir H; Celebi G; Oztoprak N; Aktaş E
    Mikrobiyol Bul; 2008 Jul; 42(3):509-14. PubMed ID: 18822897
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Ampicillin plus ceftriaxone for high-level aminoglycoside-resistant Enterococcus faecalis endocarditis.
    Singh A
    Ann Intern Med; 2008 Feb; 148(3):243; author reply 243. PubMed ID: 18252687
    [No Abstract]   [Full Text] [Related]  

  • 19. Treatment of experimental endocarditis due to Enterococcus faecalis using once-daily dosing regimen of gentamicin plus simulated profiles of ampicillin in human serum.
    Gavaldà J; Cardona PJ; Almirante B; Capdevila JA; Laguarda M; Pou L; Crespo E; Pigrau C; Pahissa A
    Antimicrob Agents Chemother; 1996 Jan; 40(1):173-8. PubMed ID: 8787901
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A surveillance of high-level gentamicin-resistant enterococcal bacteremia.
    Araoka H; Kimura M; Yoneyama A
    J Infect Chemother; 2011 Jun; 17(3):433-4. PubMed ID: 21042826
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.